Article
Melanoma Treatments: Advances and Mechanisms.
Journal of cellular physiology - 1 Nov 2015
Marzuka Alexander, Huang Laura, Theodosakis Nicholas, Bosenberg Marcus
Abstract excerpt
Advances in the understanding of the molecular pathogenesis of melanoma and in cancer immunology have led to the rational design and recent clinical implementation of a variety of novel therapies for metastatic melanoma. BRAF and MEK inhibitors that target the MAPK pathway have high rates of clinical response in BRAF-mutant melanoma. Therapies that modulate the immune response to melanoma, including monoclonal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
